Ok. @esicm #lives2021 🔥 HOT TOPIC 🔥
Results of the HYPO-ECMO study- therapeutic hypothermia post cardiogenic shock requiring ECMO
clinicaltrials.gov/ct2/show/NCT02…
Physiological rationale and clinical question
Study design and end points
Primary =30 day mortality
#LIVES2021
Primary outcome measure
No statistically significant difference (42 vs 51%; P= 0.13)
#LIVES2021
The obligatory Bayesian analysis @redneeraj #LIVES2021
Limitations and conclusion #lives2021
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.